Received Nov 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | jb4k2 | IM / LA |
Patient was administered with Engerix- B 10mcg/0.5mL (Pedriatic dose) instead of Engerix- B 20mcg/1mL (Adult dose). Patient was reached and notified, no side effects were reported by the patient.
No illnesses or health conditions were reported by the patient.
No illnesses or health conditions were reported by the patient.
No current use of any medications or dietary supplements were provided by the patient after being interviewed.
No allergies to any food or medications were provided by the patient.
Patient was administered with Engerix- B 10mcg/0.5mL (Pedriatic dose) instead of Engerix- B 20mcg/1mL (Adult dose). Patient was reached and notified, no side effects were reported by the patient.